AIIMS Delhi to screen children for Covaxin trials
June 7, 2021
49
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Mirror Now Episodes Around June 7, 2021
See what was published immediately before and after this episode.
3:18Now PlayingAIIMS Delhi to screen children for Covaxin trials
YouTube Description
as posted by the channelSome breaking inputs coming in regarding the COVID vaccine situation in the country reveals that All India Institute of Medical Sciences (AIIMS), Delhi is about to begin screening children between ages 12 and 18 years for clinical trials of Covaxin from today. This comes after receiving permission from the Drugs Controller General of India (DCGI) for the trial of the vaccine developed by the Hyderabad-based pharma firm Bharat Biotech and the Indian Council of Medical Research (ICMR). DGCI's approval for trials was followed by a recommendation by the Subject Expert Committee. Watch the full video to know more about this story and stay updated with the latest news, breaking developments and new stories only on Mirror Now.
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.